NCT04270630 is a NA clinical trial of Shared Decision Aid in NSTEMI, sponsored by NYU Langone Health.

Who is sponsoring NCT04270630?

NCT04270630 is sponsored by NYU Langone Health.

What drugs are being tested in NCT04270630?

Interventions in NCT04270630: Shared Decision Aid.

Is NCT04270630 still recruiting?

NCT04270630 is currently completed. Last updated 3 July 2023.

Last reviewed 2023-07-03 · How we verify

NCT04270630

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI

Completed NA Last updated 3 July 2023

What this trial tests

NA trial testing Shared Decision Aid in NSTEMI in 14 participants. Completed in 1 December 2022.

Timeline

1 July 2020

Primary endpoint
1 December 2022

1 December 2022

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	1 July 2020
Primary completion	1 December 2022
Estimated completion	1 December 2022
Sites	1 location across United States

Drugs / interventions tested

Shared Decision Aid

Conditions studied

NSTEMI — all drugs for NSTEMI →

Sponsor

NYU Langone Health — full company profile →

Who can join

75 and older, any sex, with NSTEMI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a single-center, prospective, un-blinded, randomized controlled trial evaluating a decision aid tool for older patients considering left heart catheterization (LHC) as treatment for non-ST elevation myocardial infarction (NSTEMI). The study population is 50 total inpatients (25 per study arm) with NSTEMI eligible for elective LHC. The first arm is the control group that will receive standard of care, while the second arm will have access to the decision aid and shared-decision making conversation with one of the co-investigators. Baseline characteristics and surveys/questionnaire data will be collected after study intervention (as applicable), and prior to final decision regarding LHC. Statistical analyses will be conducted on the primary endpoint, decisional conflict score, as well as on various secondary endpoints.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Decision aids for people facing health treatment or screening decisions.
Stacey D, Lewis KB, Smith M, Carley M, et al · · 2024 · cited 203× · PMID 38284415 · DOI 10.1002/14651858.cd001431.pub6

Verify or expand the search:

Other recruiting trials for NSTEMI

Currently open trials in the same condition.

NCT06528821 — AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS · active not recruiting
NCT05764057 — DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction · Phase 3 · recruiting
NCT05800951 — Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock · active not recruiting
NCT04988672 — OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting W · recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04270630 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 3 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04270630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing